WASHINGTON, July 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes ...
Marban reiterated confidence in regulatory timelines and potential approval, stating, "We aim to have over 100 patients transition from clinical to commercial product following potential BLA approval.
Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phase FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results